Arruda L K, Ferriani V P, Vailes L D, Pomés A, Chapman M D
Departmento Biologia Celular e Molecular, Faculdade de Medicina de Ribeirão Preto, SP, Brazil.
Curr Allergy Asthma Rep. 2001 Sep;1(5):466-73. doi: 10.1007/s11882-001-0035-1.
Cockroach allergy has been recognized as an important cause of asthma. Exposure to high levels of cockroach allergens in the home is a major risk factor for symptoms in sensitized individuals. Previously identified allergens from Blatella germanica and Periplaneta americana include Bla g 2 (inactive aspartic proteinase), Bla g 4 (calycin), Bla g 5 (glutathione-S-transferase), Bla g 6 (troponin), the Group 1 cross-reactive allergens Bla g 1 and Per a 1, Per a 3 (arylphorin), and Per a 7 (tropomyosin). The primary site of cockroach allergen accumulation is the kitchen. However, lower levels of allergen can be found in bedding, on the bedroom floor, and in sofa dust. Strategies for decreasing exposure to cockroach have been investigated. The results suggest that a sustained decrease in cockroach allergen levels is difficult to accomplish, even after successful extermination of cockroach populations. The use of recombinant cockroach allergens may lead to the development of new approaches to asthma treatment in the future.
蟑螂过敏已被确认为哮喘的一个重要病因。在家中接触高水平的蟑螂过敏原是致敏个体出现症状的主要危险因素。先前从德国小蠊和美洲大蠊中鉴定出的过敏原包括Bla g 2(无活性天冬氨酸蛋白酶)、Bla g 4(亲环蛋白)、Bla g 5(谷胱甘肽-S-转移酶)、Bla g 6(肌钙蛋白)、第1组交叉反应性过敏原Bla g 1和Per a 1、Per a 3(芳基载体蛋白)以及Per a 7(原肌球蛋白)。蟑螂过敏原积累的主要部位是厨房。然而,在床上用品、卧室地板和沙发灰尘中也能发现较低水平的过敏原。已对减少接触蟑螂的策略进行了研究。结果表明,即使在成功消灭蟑螂种群后,也很难持续降低蟑螂过敏原水平。重组蟑螂过敏原的使用可能会在未来带来哮喘治疗的新方法。